sodium zirconium cyclosilicate 5000 MG Powder for Oral Suspension [Lokelma]
RxNorm concept 2047639, branded drug (sbd). Prescribable name: LOKELMA 5 GM Powder for Oral Suspension.
- RxCUI
- 2047639
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2047639 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Lokelma 5 GM Powder for Oral Suspension; Lokelma 5000 MG Powder for Oral Suspension
Related concepts
- sodium zirconium cyclosilicate 5000 MG (SCDC, consists of)
- sodium zirconium cyclosilicate 5000 MG [Lokelma] (SBDC, consists of)
- Powder for Oral Suspension (DF, has dose form)
- Lokelma (BN, has ingredient)
- sodium zirconium cyclosilicate 5000 MG Powder for Oral Suspension (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2047639 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2047639 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2047639. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.